Key result
Indomethacin treatment successfully closed a symptomatic patent ductus arteriosus in a full-term infant, indicating it may be a useful therapy for this condition.
Population
Full-term infant with symptomatic patent ductus arteriosus (n=1)
Design
Case_report
Authors
Loading...
Hypothesis-generating for indomethacin in symptomatic PDA of term infants; prospective trials needed before clinical adoption.
Indomethacin may be a useful therapy for symptomatic patent ductus arteriosus in full-term infants.
Tanabe et al. (2019) studied this question. Indomethacin treatment successfully closed a symptomatic patent ductus arteriosus in a full-term infant, indicating it may be a useful therapy for this condition.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: